Oscar Health, Inc. (OSCR) Laps the Stock Market: Here’s Why

Oscar Health, Inc. (OSCR) ended the recent trading session at $11.92, demonstrating a +1.62% change from the preceding day’s closing price. This change outpaced the S&P 500’s 0.11% gain on the day. On the other hand, the Dow registered a loss of 0.13%, and the technology-centric Nasdaq increased by 0.18%.

Prior to today’s trading, shares of the company had lost 22.06% lagged the Finance sector’s loss of 4.76% and the S&P 500’s loss of 4.28%.

Market participants will be closely following the financial results of Oscar Health, Inc. in its upcoming release. In that report, analysts expect Oscar Health, Inc. to post earnings of $1.21 per share. This would mark year-over-year growth of 31.52%. Meanwhile, the latest consensus estimate predicts the revenue to be $4.89 billion, indicating a 60.62% increase compared to the same quarter of the previous year.

For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.2 per share and a revenue of $18.91 billion, signifying shifts of +111.83% and +61.62%, respectively, from the last year.

It’s also important for investors to be aware of any recent modifications to analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. As a result, upbeat changes in estimates indicate analysts’ favorable outlook on the business health and profitability.

Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.

The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. At present, Oscar Health, Inc. boasts a Zacks Rank of #3 (Hold).

Investors should also note Oscar Health, Inc.’s current valuation metrics, including its Forward P/E ratio of 57.69. This denotes a premium relative to the industry average Forward P/E of 9.38.

The Insurance – Multi line industry is part of the Finance sector. This group has a Zacks Industry Rank of 148, putting it in the bottom 40% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.